HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/4/E945    most recent 90292.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liang, H. Articles by Ward, W. F. Search for Related Content PubMed PubMed Citation Articles by Liang, H. Articles by Ward, W. F.

Whole body overexpression of PGC-1 has opposite effects on hepatic and muscle insulin sensitivity

¹University of Texas Health Science Center at San Antonio, ²Texas Diabetes Institute, and ⁴Barshop Institute for Longevity and Aging Studies, San Antonio, Texas; and ³University of Pittsburgh, Pittsburgh, Pennsylvania

Submitted 13 March 2008 ; accepted in final form 6 February 2009

Type 2 diabetes is characterized by fasting hyperglycemia, secondary to hepatic insulin resistance and increased glucose production. Peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) is a transcriptional coactivator that is thought to control adaptive responses to physiological stimuli. In liver, PGC-1 expression is induced by fasting, and this effect promotes gluconeogenesis. To examine whether PGC-1 is involved in the pathogenesis of hepatic insulin resistance, we generated transgenic (TG) mice with whole body overexpression of human PGC-1 and evaluated glucose homeostasis with a euglycemic-hyperinsulinemic clamp. PGC-1 was moderately (2-fold) overexpressed in liver, skeletal muscle, brain, and heart of TG mice. In liver, PGC-1 overexpression resulted in increased expression of hepatocyte nuclear factor-4 and the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase. PGC-1 overexpression caused hepatic insulin resistance, manifested by higher glucose production and diminished insulin suppression of gluconeogenesis. Paradoxically, PGC-1 overexpression improved muscle insulin sensitivity, as evidenced by elevated insulin-stimulated Akt phosphorylation and peripheral glucose disposal. Content of myoglobin and troponin I slow protein was increased in muscle of TG mice, indicating fiber-type switching. PGC-1 overexpression also led to lower reactive oxygen species production by mitochondria and reduced IKK/IB signaling in muscle. Feeding a high-fat diet to TG mice eliminated the increased muscle insulin sensitivity. The dichotomous effect of PGC-1 overexpression in liver and muscle suggests that PGC-1 is a fuel gauge that couples energy demands (muscle) with the corresponding fuel supply (liver). Thus, under conditions of physiological stress (i.e., prolonged fast and exercise training), increased hepatic glucose production may help sustain glucose utilization in peripheral tissues.

diabetes; phosphoenolpyruvate carboxykinase; glucose-6-phosphatase; gluconeogenesis

This article has been cited by other articles:

				Y. Wang, W. Feng, W. Xue, Y. Tan, D. W. Hein, X.-K. Li, and L. Cai Inactivation of GSK-3{beta} by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling Diabetes, June 1, 2009; 58(6): 1391 - 1402. [Abstract] [Full Text] [PDF]